Point72 Asset Management, L.P. 13D and 13G filings for Design Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-28 4:05 pm Purchase | 2025-08-27 | 13G | Design Therapeutics, Inc. DSGN | Point72 Asset Management, L.P. | 2,942,719 5.200% | 2,942,719 (New Position) | Filing |